Presentation on
Ankylosing
Spondylitis
DR. AVIJIT DAS
&
DR. MD ABDUL WAHED
Intern Doctor, Department of Medicine,
Southern Medical College & Hospital.
Spondyloarthritides
The spondyloarthritides comprise a group of related inflammatory diseases that show overlap in
their clinical features and have a shared immunogenetic association with HLA-B27 . The
spectrum of spondyloarthritis (SpA) includes:
1. axial spondyloarthritis (axSpA) comprising:
1. non-radiographic SpA (nr-axSpA)
2. radiographic axSpA (ankylosing spondylitis [AS])
2. Reactive SpA
3.Psoriatic arthritis
4.Arthritis with inflammatory bowel disease (enteropathic SpA).
ASAS- EULAR recommendations
for the management of axSpA
• Patients should be educated about axSpA and encouraged to exercise on a
regular basis and stop smoking; physiotherapy should be considered.
• Patients suffering from pain and stiffness should use an NSAID as first- line drug
treatment up to the maximum dose, taking risks and benefits into account. For
patients who respond well to NSAIDs, continuous use is preferred if needed to
control symptoms.
• Analgesics, such as paracetamol and opioid- (like) drugs, might be considered
for residual pain after previously recommended treatments have failed, are
contraindicated, and/or poorly tolerated.
• Glucocorticoid injections directed to the local site of musculoskeletal
inflammation may be considered. Patients with axial disease should not receive
long- term treatment with systemic glucocorticoids.
ASAS- EULAR recommendations for the
management of axSpA
• Patients with purely axial disease should normally not be treated with csDMARDs;
sulfasalazine may be considered in patients with peripheral arthritis.
• TNFi, IL- 17i† should be considered in patients with persistently high disease activity despite
conventional treatments
• If there is a history of recurrent uveitis or active IBD§, preference should be given to a
monoclonal antibody against TNF¶ In patients with significant psoriasis, an IL- 17i† may be
preferred.
• Following a first b/tsDMARD failure, switching to another DMARD (TNFi or IL- 17i†) should be
considered.
• Total hip arthroplasty should be considered in patients with refractory pain or disability and
radiographic evidence of structural damage, independent of age; spinal corrective osteotomy
in specialised centres may be considered in patients with severe disabling deformity.
ANKYLOSING SPONDYLITIS
• It is a chronic inflammatory seronegative arthritis
characterized by progressive stiffening and fusion of
axial skeleton. Common in young adult, 20–40 years,
Male:Female = 3:1. [M:F= 3:1]
• Etiology: Etiology is unknown, but probable,
etiologic factors are:
• Genetic predisposition–5-6% of people with AS share
the genetic marker HLA-B27
• Bacterias - Klebsiella pneumoniae and some other
Enterobacterias.
Pathomorphology
Pathological changes in ankylosing spondylitis
o An inflammatory arthritis affecting the synovium, capsule and ligaments
around the joints, as well as the insertions of tendons into bone.
o Inflammation is known as an enthesopathy (around the spine and pelvis).
o Involves an imbalance in bone production and reabsorption.(Increased levels of
cytokines: effect on bone mineral absorption leading to osteoporosis early on
in the disease process) .
o Bony ridge form at periphery of IV joints leading to ossification of annulus
fibrosis & surrounding tissue (seen in radiography & term as Syndesmophytes)
o Ligamentous calcification (posterior and anterior longitudinal ligaments
and the inferior and superior interspinous ligaments)
o (appearance on XRay : bamboo spine).
o AS occurs in (symphysis pubis, costovertebral and manubriosternal joints)
Symptoms
Symptoms (early AS)
1. Pain in sacroiliac and lower back regions:
➡permanent; dull
➡worsens in rest; in the morning;nocturnal
➡reliefs in motion; in the afternoon
2. Buttock pain:
irradiates into posterior surface of hip
migrates from left to right gluteus
3. Lower back stiffness:
in the morning,for 30 minutes
≥
➡reliefs after activity, warm shower
4. Chest pain:
mimicries intercostal neuralgia and intercostal
muscles myositis worsens in coughing,
sneezing, deep breathing.
Symptoms
5. Stiffness and tenderness of back
muscles.
6. Flattening of lumbar lordosis
7. Bilateral sacroilitis.
8. Enthesopathies - pain in the site of
ligament attachment to bone:
➡Iliac crests
➡Trochanters
➡spinous processes of vertebrae
➡costovertebral joints
9. Extra-articular manifestations - usually
eyes affection (anterior uveitis); bilateral,
acute onset, lasts for 2-3 months,
registered in 30% of patients.
Symptoms (advanced AS)
1. Pain in different segments of spine.
2. Question mark posture
3. Atrophy of back muscles.
4. Decreased thorax excursion.
5. Decreased articulations in spine.
6. Ankylosis of sacroiliac
and intervertebral joints.
7. Cutaneous lesions - that are
identical topustular psoriasis
8. Cardiovascular system involvement:
➡ Aortitis
➡ aortic insufficiency
➡ pericarditis, myocarditis
9. Bronchopulmonary system involvement
- fibrosis of apical lung segments.
10. Urinary system involvement
➡ Amyloidosis
➡ IgA-nephropathy
11. Gastrointestinal system involvement
➡ Vulcerative colitis
➡ Crohn's disease
Signs
• There is loss of lumbar lordosis, thoracic kyphosis and compensatory
hyperextension of neck (in advanced stage, question mark sign
“?” or stoped posture).
• The patient is unable to look up and unable to turn to any side without
movement of whole body.
• Restricted movement of spine in all directions.
• Standing against the wall, the patient is unable to make contact
between the occiput of head and the wall.
• Sacroiliitis, Achilles tendinitis and plantar fasciitis are present.
Question mark posture
Question mark posture, or suppliant posture -loss of lumbar lordosis, fixed
kyphosis,compensated extension cervical spine, protruberant abdomen
Question mark posture
Question mark posture, or suppliant posture -loss of lumbar lordosis, fixed
kyphosis,compensated extension cervical spine, protruberant abdomen
Question mark posture
Question mark posture, or suppliant posture -loss of lumbar lordosis, fixed
kyphosis,compensated extension cervical spine, protruberant abdomen
Question mark posture
Question mark posture, or suppliant posture -loss of lumbar lordosis, fixed
kyphosis,compensated extension cervical spine, protruberant abdomen
Question mark posture
Question mark posture, or suppliant posture -loss of lumbar lordosis, fixed
kyphosis,compensated extension cervical spine, protruberant abdomen
Question mark posture
Question mark posture, or suppliant posture -loss of lumbar lordosis, fixed
kyphosis,compensated extension cervical spine, protruberant abdomen
Question mark posture
Question mark posture, or suppliant posture -loss of lumbar lordosis, fixed
kyphosis,compensated extension cervical spine, protruberant abdomen
Question mark posture
Question mark posture, or suppliant posture -loss of lumbar lordosis, fixed
kyphosis,compensated extension cervical spine, protruberant abdomen
Question mark posture
Question mark posture, or suppliant posture -loss of lumbar lordosis, fixed
kyphosis,compensated extension cervical spine, protruberant abdomen
Question mark posture
Question mark posture, or suppliant posture -loss of lumbar lordosis, fixed
kyphosis,compensated extension cervical spine, protruberant abdomen
Question mark posture
Question mark posture, or suppliant posture -loss of lumbar lordosis, fixed
kyphosis,compensated extension cervical spine, protruberant abdomen
Question mark posture
Question mark posture, or suppliant posture -loss of lumbar lordosis, fixed
kyphosis,compensated extension cervical spine, protruberant abdomen
Question mark posture
Question mark posture, or suppliant posture -loss of lumbar lordosis, fixed
kyphosis,compensated extension cervical spine, protruberant abdomen
Question mark posture
Question mark posture, or suppliant posture -loss of lumbar lordosis, fixed
kyphosis,compensated extension cervical spine, protruberant abdomen
TREATMENT
1. Regular physical therapy
2. NSAIDS :
Indomethacin (up to maximum of 50 mg PO tid)
COX-2 inhibitors
3. Sulfasalazine, in doses of 2 to 3 g/d- Effective for axial and peripheral arthritis
4. Methotrexate, in doses of 10 to 25 mg/wk- primarily for peripheral arthritis
5. Local Corticosteroids injection- for persistent synovitis and enthesopathy
6. Medications to avoid- Long term Systemic Corticosteroids, gold and Penicillamine
7. Anti-TNF-a therapy - heralded a revolution in the management of AS.
Infliximab (chimeric human/mouse anti-TNF-a monoclonal antibody)
Etanercept (soluble p75 TNF-a receptor-IgG fusion protein)
have shown rapid, profound, and sustained reductions in all clinical and laboratory measures
of disease activity
8. Pamidronate, thalidomide, a-emitting isotope 224Ra
9. Most common indication for surgery - severe hip joint arthritis, total hip arthroplasty.
PHYSIOTHERAPY TREATMENT:
Regular physiotherapy is very essential in the management of a patient
of AS and only physiotherapist is the person who can help the patient to
fight with the disease.
relevant physiotherapy modalities in the management of AS include :
Supervised & unsupervised exercises
Training
Manual therapy
Massage
Hydrotherapy
Electrotherapy
Acupuncture
Patient information & educational programs
PHYSIOTHERAPY TREATMENT:
General instruction to patients:-
 Make the exercise part of your daily routine.
 Try to do a complete set of exercises at least twice daily at a
time convenient to you.
 Heat and cold application amy precede exercises to
enhance relaxation and decrease pain.
 Perform only those exercises given to you by your
physiotherapist.
 Perform exercises on a firm surface.
 Exercise slowly with a smooth motion, do not rush.
 Avoid holding your breath while exercising.
 Modify the exercise regime during an acute attack and
contact your physical therapist if you have any complaints
or problems with the exercises.
CREDITS: This presentation template was created by
Slidesgo, including icons by Flaticon, and
infographics & images by Freepik
THANK
You!

Presentation on Ankylosing Spondylitis BY DR AVIJIT AND DR WAHED

  • 1.
    Presentation on Ankylosing Spondylitis DR. AVIJITDAS & DR. MD ABDUL WAHED Intern Doctor, Department of Medicine, Southern Medical College & Hospital.
  • 2.
    Spondyloarthritides The spondyloarthritides comprisea group of related inflammatory diseases that show overlap in their clinical features and have a shared immunogenetic association with HLA-B27 . The spectrum of spondyloarthritis (SpA) includes: 1. axial spondyloarthritis (axSpA) comprising: 1. non-radiographic SpA (nr-axSpA) 2. radiographic axSpA (ankylosing spondylitis [AS]) 2. Reactive SpA 3.Psoriatic arthritis 4.Arthritis with inflammatory bowel disease (enteropathic SpA).
  • 6.
    ASAS- EULAR recommendations forthe management of axSpA • Patients should be educated about axSpA and encouraged to exercise on a regular basis and stop smoking; physiotherapy should be considered. • Patients suffering from pain and stiffness should use an NSAID as first- line drug treatment up to the maximum dose, taking risks and benefits into account. For patients who respond well to NSAIDs, continuous use is preferred if needed to control symptoms. • Analgesics, such as paracetamol and opioid- (like) drugs, might be considered for residual pain after previously recommended treatments have failed, are contraindicated, and/or poorly tolerated. • Glucocorticoid injections directed to the local site of musculoskeletal inflammation may be considered. Patients with axial disease should not receive long- term treatment with systemic glucocorticoids.
  • 7.
    ASAS- EULAR recommendationsfor the management of axSpA • Patients with purely axial disease should normally not be treated with csDMARDs; sulfasalazine may be considered in patients with peripheral arthritis. • TNFi, IL- 17i† should be considered in patients with persistently high disease activity despite conventional treatments • If there is a history of recurrent uveitis or active IBD§, preference should be given to a monoclonal antibody against TNF¶ In patients with significant psoriasis, an IL- 17i† may be preferred. • Following a first b/tsDMARD failure, switching to another DMARD (TNFi or IL- 17i†) should be considered. • Total hip arthroplasty should be considered in patients with refractory pain or disability and radiographic evidence of structural damage, independent of age; spinal corrective osteotomy in specialised centres may be considered in patients with severe disabling deformity.
  • 8.
    ANKYLOSING SPONDYLITIS • Itis a chronic inflammatory seronegative arthritis characterized by progressive stiffening and fusion of axial skeleton. Common in young adult, 20–40 years, Male:Female = 3:1. [M:F= 3:1] • Etiology: Etiology is unknown, but probable, etiologic factors are: • Genetic predisposition–5-6% of people with AS share the genetic marker HLA-B27 • Bacterias - Klebsiella pneumoniae and some other Enterobacterias.
  • 9.
  • 10.
    Pathological changes inankylosing spondylitis o An inflammatory arthritis affecting the synovium, capsule and ligaments around the joints, as well as the insertions of tendons into bone. o Inflammation is known as an enthesopathy (around the spine and pelvis). o Involves an imbalance in bone production and reabsorption.(Increased levels of cytokines: effect on bone mineral absorption leading to osteoporosis early on in the disease process) . o Bony ridge form at periphery of IV joints leading to ossification of annulus fibrosis & surrounding tissue (seen in radiography & term as Syndesmophytes) o Ligamentous calcification (posterior and anterior longitudinal ligaments and the inferior and superior interspinous ligaments) o (appearance on XRay : bamboo spine). o AS occurs in (symphysis pubis, costovertebral and manubriosternal joints)
  • 11.
    Symptoms Symptoms (early AS) 1.Pain in sacroiliac and lower back regions: ➡permanent; dull ➡worsens in rest; in the morning;nocturnal ➡reliefs in motion; in the afternoon 2. Buttock pain: irradiates into posterior surface of hip migrates from left to right gluteus 3. Lower back stiffness: in the morning,for 30 minutes ≥ ➡reliefs after activity, warm shower 4. Chest pain: mimicries intercostal neuralgia and intercostal muscles myositis worsens in coughing, sneezing, deep breathing.
  • 12.
    Symptoms 5. Stiffness andtenderness of back muscles. 6. Flattening of lumbar lordosis 7. Bilateral sacroilitis. 8. Enthesopathies - pain in the site of ligament attachment to bone: ➡Iliac crests ➡Trochanters ➡spinous processes of vertebrae ➡costovertebral joints 9. Extra-articular manifestations - usually eyes affection (anterior uveitis); bilateral, acute onset, lasts for 2-3 months, registered in 30% of patients.
  • 13.
    Symptoms (advanced AS) 1.Pain in different segments of spine. 2. Question mark posture 3. Atrophy of back muscles. 4. Decreased thorax excursion. 5. Decreased articulations in spine. 6. Ankylosis of sacroiliac and intervertebral joints. 7. Cutaneous lesions - that are identical topustular psoriasis 8. Cardiovascular system involvement: ➡ Aortitis ➡ aortic insufficiency ➡ pericarditis, myocarditis 9. Bronchopulmonary system involvement - fibrosis of apical lung segments. 10. Urinary system involvement ➡ Amyloidosis ➡ IgA-nephropathy 11. Gastrointestinal system involvement ➡ Vulcerative colitis ➡ Crohn's disease
  • 14.
    Signs • There isloss of lumbar lordosis, thoracic kyphosis and compensatory hyperextension of neck (in advanced stage, question mark sign “?” or stoped posture). • The patient is unable to look up and unable to turn to any side without movement of whole body. • Restricted movement of spine in all directions. • Standing against the wall, the patient is unable to make contact between the occiput of head and the wall. • Sacroiliitis, Achilles tendinitis and plantar fasciitis are present.
  • 15.
    Question mark posture Questionmark posture, or suppliant posture -loss of lumbar lordosis, fixed kyphosis,compensated extension cervical spine, protruberant abdomen
  • 17.
    Question mark posture Questionmark posture, or suppliant posture -loss of lumbar lordosis, fixed kyphosis,compensated extension cervical spine, protruberant abdomen
  • 18.
    Question mark posture Questionmark posture, or suppliant posture -loss of lumbar lordosis, fixed kyphosis,compensated extension cervical spine, protruberant abdomen
  • 19.
    Question mark posture Questionmark posture, or suppliant posture -loss of lumbar lordosis, fixed kyphosis,compensated extension cervical spine, protruberant abdomen
  • 20.
    Question mark posture Questionmark posture, or suppliant posture -loss of lumbar lordosis, fixed kyphosis,compensated extension cervical spine, protruberant abdomen
  • 21.
    Question mark posture Questionmark posture, or suppliant posture -loss of lumbar lordosis, fixed kyphosis,compensated extension cervical spine, protruberant abdomen
  • 22.
    Question mark posture Questionmark posture, or suppliant posture -loss of lumbar lordosis, fixed kyphosis,compensated extension cervical spine, protruberant abdomen
  • 23.
    Question mark posture Questionmark posture, or suppliant posture -loss of lumbar lordosis, fixed kyphosis,compensated extension cervical spine, protruberant abdomen
  • 24.
    Question mark posture Questionmark posture, or suppliant posture -loss of lumbar lordosis, fixed kyphosis,compensated extension cervical spine, protruberant abdomen
  • 25.
    Question mark posture Questionmark posture, or suppliant posture -loss of lumbar lordosis, fixed kyphosis,compensated extension cervical spine, protruberant abdomen
  • 26.
    Question mark posture Questionmark posture, or suppliant posture -loss of lumbar lordosis, fixed kyphosis,compensated extension cervical spine, protruberant abdomen
  • 27.
    Question mark posture Questionmark posture, or suppliant posture -loss of lumbar lordosis, fixed kyphosis,compensated extension cervical spine, protruberant abdomen
  • 28.
    Question mark posture Questionmark posture, or suppliant posture -loss of lumbar lordosis, fixed kyphosis,compensated extension cervical spine, protruberant abdomen
  • 29.
    Question mark posture Questionmark posture, or suppliant posture -loss of lumbar lordosis, fixed kyphosis,compensated extension cervical spine, protruberant abdomen
  • 30.
    TREATMENT 1. Regular physicaltherapy 2. NSAIDS : Indomethacin (up to maximum of 50 mg PO tid) COX-2 inhibitors 3. Sulfasalazine, in doses of 2 to 3 g/d- Effective for axial and peripheral arthritis 4. Methotrexate, in doses of 10 to 25 mg/wk- primarily for peripheral arthritis 5. Local Corticosteroids injection- for persistent synovitis and enthesopathy 6. Medications to avoid- Long term Systemic Corticosteroids, gold and Penicillamine 7. Anti-TNF-a therapy - heralded a revolution in the management of AS. Infliximab (chimeric human/mouse anti-TNF-a monoclonal antibody) Etanercept (soluble p75 TNF-a receptor-IgG fusion protein) have shown rapid, profound, and sustained reductions in all clinical and laboratory measures of disease activity 8. Pamidronate, thalidomide, a-emitting isotope 224Ra 9. Most common indication for surgery - severe hip joint arthritis, total hip arthroplasty.
  • 31.
    PHYSIOTHERAPY TREATMENT: Regular physiotherapyis very essential in the management of a patient of AS and only physiotherapist is the person who can help the patient to fight with the disease. relevant physiotherapy modalities in the management of AS include : Supervised & unsupervised exercises Training Manual therapy Massage Hydrotherapy Electrotherapy Acupuncture Patient information & educational programs
  • 32.
    PHYSIOTHERAPY TREATMENT: General instructionto patients:-  Make the exercise part of your daily routine.  Try to do a complete set of exercises at least twice daily at a time convenient to you.  Heat and cold application amy precede exercises to enhance relaxation and decrease pain.  Perform only those exercises given to you by your physiotherapist.  Perform exercises on a firm surface.  Exercise slowly with a smooth motion, do not rush.  Avoid holding your breath while exercising.  Modify the exercise regime during an acute attack and contact your physical therapist if you have any complaints or problems with the exercises.
  • 33.
    CREDITS: This presentationtemplate was created by Slidesgo, including icons by Flaticon, and infographics & images by Freepik THANK You!